Key Insights

Highlights

Success Rate

85% trial completion

Published Results

30 trials with published results (33%)

Research Maturity

52 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

9.8%

9 terminated out of 92 trials

Success Rate

85.2%

-1.3% vs benchmark

Late-Stage Pipeline

24%

22 trials in Phase 3/4

Results Transparency

58%

30 of 52 completed with results

Key Signals

30 with results85% success

Data Visualizations

Phase Distribution

83Total
Not Applicable (38)
Early P 1 (1)
P 1 (7)
P 2 (15)
P 3 (11)
P 4 (11)

Trial Status

Completed52
Unknown15
Terminated9
Recruiting8
Active Not Recruiting3
Withdrawn2

Trial Success Rate

85.2%

Benchmark: 86.5%

Based on 52 completed trials

Clinical Trials (92)

Showing 20 of 20 trials
NCT07348783Not ApplicableRecruiting

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD

NCT07292090Not ApplicableActive Not Recruiting

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study

NCT07699549Completed

Long-term Atogepant in Real-world Practice

NCT06459635Recruiting

Migraine Attack Pain Phase Prediction Study

NCT07667621Phase 1Not Yet Recruiting

A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department

NCT07634146Not ApplicableNot Yet Recruiting

Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study

NCT07476053Not ApplicableRecruitingPrimary

Light Exposure, Migraine Outcomes, and Sleep Quality

NCT06874361Not ApplicableCompleted

Cooling to Alleviate Migraine #3

NCT07295587Enrolling By InvitationPrimary

Assessment of the Impact of Headache on the Employee Population of Libbs Pharmaceutical Ltd

NCT07292506Not ApplicableActive Not Recruiting

The Impact of Acupuncture on Biomarkers of Brain Injury and Inflammatory Response in Migraine

NCT06203873Not ApplicableRecruiting

A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine

NCT05943457Not ApplicableRecruitingPrimary

Vitamin K2 Supplementation in Adult Episodic Migraine

NCT07015125Not ApplicableCompleted

Evaluation of a Wearable Device for Acute Treatment of Migraines

NCT03971071Phase 4CompletedPrimary

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

NCT07022496Phase 4Recruiting

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

NCT07015411Not ApplicableRecruitingPrimary

Neuro-Complex & Multi Supplements for Migraine Prevention

NCT05780671CompletedPrimary

Oxygen in Migraine Treatment

NCT01630044Not ApplicableCompletedPrimary

Neurostimulation Device for Treatment of Migraine Headache

NCT06798259Active Not RecruitingPrimary

Autonomic Dysfunction in Patients With Migraine: Cardiovascular and Neurophysiology Assessment

NCT03097536Not ApplicableTerminatedPrimary

Migraine and Homeostasis:What Can we Learn From Glucose

Scroll to load more

Research Network

Activity Timeline